A 40-Year-Old Woman With Exertional Dyspnea and Unexplained Hypoxia. (PubMed, Chest) - Sep 10, 2026 - "The patient received sequential ROS1-targeted therapy (crizotinib, entrectinib, repotrectinib) plus local therapies for metastatic lesions. She had no history of smoking, substance misuse, or alcohol consumption. No family history of genetic diseases was reported."
IO biomarker • Journal • Cough • Genetic Disorders • Lung Adenocarcinoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Pulmonary Disease • Respiratory Diseases • Solid Tumor • PD-L1 • ROS1
|
|
Li-Song Qiao; Tao Gu; Wei-Qing Meng; Xiao-Mao Xu; Xue-Feng Zhong; Yao-Dan Liang; Yu-Xia Wang
|